Scipher Medicine, founded in 2015, is a precision medicine platform focusing on analyzing patients' molecular data. Their mission is to enhance the accuracy of prescriptions and therapies, thereby tailoring medical treatments to individual patients' needs. By leveraging the power of molecular data, Scipher Medicine strives to optimize therapeutic outcomes and reduce the trial-and-error nature of traditional prescribing. Scipher Medicine is headquartered in Waltham, Massachusetts.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
02/24/2022 | Series D | $120.72MM | $xx.xx | $49.86B | Alumni Ventures, Amoon, Cowen Healthcare Investments, Echo Health Ventures, Hitachi Ventures, Khosla Ventures, Laurion Capital, Monashee Investment Management, Neuberger Berman, Northpond Ventures, Optum Ventures | |
Price per Share
$xx.xx
Shares Outstanding
3,166,980
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alumni Ventures, Amoon, Cowen Healthcare Investments, Echo Health Ventures, Hitachi Ventures, Khosla Ventures, Laurion Capital, Monashee Investment Management, Neuberger Berman, Northpond Ventures, Optum Ventures
|
||||||
03/25/2021 | Series C | $82MM | $xx.xx | $25.68B | Alumni Ventures, Amoon, Echo Health Ventures, Khosla Ventures, Northpond Ventures | |
Price per Share
$xx.xx
Shares Outstanding
2,806,379
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alumni Ventures, Amoon, Echo Health Ventures, Khosla Ventures, Northpond Ventures
|
||||||
02/19/2020 | Series B | $25MM | $xx.xx | $9.6B | Optum Ventures | |
Price per Share
$xx.xx
Shares Outstanding
1,452,417
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Optum Ventures
|
||||||
09/06/2018 | Series A | $9.42MM | $xx.xx | $2.93B | Khosla Ventures | |
Price per Share
$xx.xx
Shares Outstanding
1,216,331
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Khosla Ventures
|
||||||
10/20/2016 | Series Seed | $1.62MM | $xx.xx | $540.22MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
676,128
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|